Insider Transactions Reported by 25 Insiders of Kyverna Therapeutics, Inc.

Symbol
KYTX on Nasdaq
Location
Emeryville, CA

Insiders trading volume in the past year

Kyverna Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Fred E. Cohen Director, 10%+ Owner $9,580,576 29 May 2025
BETH C. SEIDENBERG Director $6,650,121 +$999,998 +18% 18 Dec 2025
Westlake BioPartners Opportunity Fund I, L.P. 10%+ Owner $6,519,877 +$999,998 +18% 18 Dec 2025
Christi Shaw Executive Chairperson, Director $561,095 12 Jan 2026
Karen Marie Walker Chief Technology Officer $276,159 -$292,776 -51% 15 Dec 2025
Sravan Kumar Emany Director $100,814 24 Feb 2026
Andrew Craig Miller Director $87,277 24 Feb 2026
CLARK IAN T. Director $35,097 29 May 2025
Mert Aktar Director $35,097 29 May 2025
DANIEL K. SPIEGELMAN Director $35,097 29 May 2025
Westlake BioPartners Fund I, L.P. 10%+ Owner 12 Feb 2024
Vida Ventures, LLC 10%+ Owner 12 Feb 2024
Warner Weston Biddle Chief Executive Officer, Director 11 Apr 2025
NAJI GEHCHAN Chief Medical & Development Officer 22 Jan 2025
MARC GRASSO Chief Financial Officer 30 Jun 2025
Bain Capital Life Sciences Investors, LLC 10%+ Owner 12 Feb 2024
Mayobanex Pujols Chief Technology Officer 09 Feb 2026
GILEAD SCIENCES, INC. 10%+ Owner 12 Feb 2024
Ryan Alexander Jones Chief Financial Officer 11 Apr 2025
Brian L. Kotzin Director 07 Feb 2024
James Bum Chung Chief Medical Officer 07 Feb 2024
Dominique Christian Borie President, Research and Development Exhibit 24 - Power of Attorney 07 Feb 2024
Stephen Constantine Liapis Director 07 Feb 2024
Northpond Ventures III GP, LLC Former 10% Owner 12 Feb 2024
Peter Maag Chief Executive Officer, Director 07 Feb 2024

Recent Insider Transactions by Companies or Individuals for Kyverna Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.